Glioblastoma Overview
Learn About Glioblastoma
View Main Condition: Brain Tumor
Wake Forest University Health Sciences
Glenn Lesser is an Oncologist and a Hematologist in Winston Salem, North Carolina. Dr. Lesser and is rated as an Elite provider by MediFind in the treatment of Glioblastoma. His top areas of expertise are Glioblastoma, Brain Tumor, Astrocytoma, Glioma, and Bone Marrow Aspiration. Dr. Lesser is currently accepting new patients.
Ucsf Medical Group Business Services
John De Groot is a Neurologist in San Francisco, California. Dr. De Groot and is rated as an Elite provider by MediFind in the treatment of Glioblastoma. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri.
Duke Health Integrated Practice Inc
Katherine Peters is a Neurologist in Durham, North Carolina. Dr. Peters and is rated as an Elite provider by MediFind in the treatment of Glioblastoma. Her top areas of expertise are Glioma, Gliomatosis Cerebri, Astrocytoma, and Brain Tumor. Dr. Peters is currently accepting new patients.
Summary: The goal of this Phase 3 clinical trial is to compare the efficacy of niraparib versus temozolomide (TMZ) in adult participants with newly-diagnosed, MGMT unmethylated glioblastoma multiforme (GBM). The main questions it aims to answer are: Does niraparib improve progression-free survival (PFS) compared to TMZ? Does niraparib improve overall survival (OS) compared to TMZ? Participants will be rand...
Summary: This is a first in human study of TNG456 alone and in combination with abemaciclib in patients with advanced or metastatic solid tumors known to have an MTAP loss. The first part of the study is an open-label, dose escalation and the second part is an open label dose expansion in specific solid tumor types with a confirmed MTAP loss. The study drug, TNG456, is a selective PRMT5 inhibitor administe...

Keep Punching supports patients, healthcare providers, and researchers in their fight to prevent and eradicate brain cancer and minimize treatment-related side effects that may adversely impact function and comfort.